Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
EMBO Molecular Medicine
|
August 28, 2024
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita
Hemanth Tummala, Amanda J Walne, Mohsin Badat, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 21, 2015
The role and interaction of imprinted genes in human fetal growth
Gudrun E Moore, Miho Ishida, Charalambos Demetriou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
Elife
|
January 10, 2019
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Yao Liang Wong, Lauren LeBon, Ana M Basso, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies
Jennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Elife
|
March 8, 2022
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
Brogan Ashley, Claire Simner, Antigoni Manousopoulou, et al.
CNS Neuroscience & Therapeutics
|
May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
Karin R Tietje, David J Anderson, R Scott Bitner, et al.
Nature
|
October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
EMBO Molecular Medicine
|
August 28, 2024
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita
Hemanth Tummala, Amanda J Walne, Mohsin Badat, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 21, 2015
The role and interaction of imprinted genes in human fetal growth
Gudrun E Moore, Miho Ishida, Charalambos Demetriou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
Elife
|
January 10, 2019
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Yao Liang Wong, Lauren LeBon, Ana M Basso, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies
Jennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Elife
|
March 8, 2022
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
Brogan Ashley, Claire Simner, Antigoni Manousopoulou, et al.
CNS Neuroscience & Therapeutics
|
May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
Karin R Tietje, David J Anderson, R Scott Bitner, et al.
Nature
|
October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Page
of 4